795 related articles for article (PubMed ID: 27896660)
1. Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.
Heise CW; Brooks DE
J Med Toxicol; 2017 Sep; 13(3):245-248. PubMed ID: 27896660
[TBL] [Abstract][Full Text] [Related]
2. 2014 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd Annual Report.
Mowry JB; Spyker DA; Brooks DE; McMillan N; Schauben JL
Clin Toxicol (Phila); 2015; 53(10):962-1147. PubMed ID: 26624241
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
[TBL] [Abstract][Full Text] [Related]
4. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report.
Bronstein AC; Spyker DA; Cantilena LR; Rumack BH; Dart RC
Clin Toxicol (Phila); 2012 Dec; 50(10):911-1164. PubMed ID: 23272763
[TBL] [Abstract][Full Text] [Related]
5. 2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report.
Mowry JB; Spyker DA; Brooks DE; Zimmerman A; Schauben JL
Clin Toxicol (Phila); 2016 Dec; 54(10):924-1109. PubMed ID: 28004588
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay.
Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A
Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498
[TBL] [Abstract][Full Text] [Related]
7. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J; Hallak J; Dursun SM; Baker G
Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
[TBL] [Abstract][Full Text] [Related]
8. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report.
Gummin DD; Mowry JB; Spyker DA; Brooks DE; Fraser MO; Banner W
Clin Toxicol (Phila); 2017 Dec; 55(10):1072-1252. PubMed ID: 29185815
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
McKenna DJ; Towers GH; Abbott F
J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
[TBL] [Abstract][Full Text] [Related]
10. Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J
Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063
[TBL] [Abstract][Full Text] [Related]
11. Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context.
Lanaro R; Mello SM; da Cunha KF; Silveira G; Corrêa-Neto NF; Hyslop S; Cabrices OG; Costa JL; Linardi A
Drug Test Anal; 2021 Mar; 13(3):664-678. PubMed ID: 33119972
[TBL] [Abstract][Full Text] [Related]
12. 2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 30th Annual Report.
Mowry JB; Spyker DA; Cantilena LR; Bailey JE; Ford M
Clin Toxicol (Phila); 2013 Dec; 51(10):949-1229. PubMed ID: 24359283
[TBL] [Abstract][Full Text] [Related]
13. Ayahuasca: What Healthcare Providers Need to Know.
Goldin D; Salani D
J Addict Nurs; 2021 Apr-Jun 01; 32(2):167-173. PubMed ID: 34060770
[TBL] [Abstract][Full Text] [Related]
14. 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report.
Bronstein AC; Spyker DA; Cantilena LR; Green JL; Rumack BH; Giffin SL
Clin Toxicol (Phila); 2010 Dec; 48(10):979-1178. PubMed ID: 21192756
[TBL] [Abstract][Full Text] [Related]
15. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report.
Bronstein AC; Spyker DA; Cantilena LR; Green JL; Rumack BH; Dart RC
Clin Toxicol (Phila); 2011 Dec; 49(10):910-41. PubMed ID: 22165864
[TBL] [Abstract][Full Text] [Related]
16. Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids
Brito-da-Costa AM; Dias-da-Silva D; Gomes NGM; Dinis-Oliveira RJ; Madureira-Carvalho Á
Pharmaceuticals (Basel); 2020 Oct; 13(11):. PubMed ID: 33114119
[TBL] [Abstract][Full Text] [Related]
17. Ayahuasca Alters Structural Parameters of the Rat Aorta.
Pitol DL; Siéssere S; Dos Santos RG; Rosa ML; Hallak JE; Scalize PH; Pereira BF; Iyomasa MM; Semprini M; Riba J; Regalo SC
J Cardiovasc Pharmacol; 2015 Jul; 66(1):58-62. PubMed ID: 25714595
[TBL] [Abstract][Full Text] [Related]
18. 2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report.
Bronstein AC; Spyker DA; Cantilena LR; Green JL; Rumack BH; Giffin SL
Clin Toxicol (Phila); 2009 Dec; 47(10):911-1084. PubMed ID: 20028214
[TBL] [Abstract][Full Text] [Related]
19. Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users.
Mello SM; Soubhia PC; Silveira G; Corrêa-Neto NF; Lanaro R; Costa JL; Linardi A
J Psychoactive Drugs; 2019; 51(1):3-11. PubMed ID: 30582439
[TBL] [Abstract][Full Text] [Related]
20. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics.
Riba J; Valle M; Urbano G; Yritia M; Morte A; Barbanoj MJ
J Pharmacol Exp Ther; 2003 Jul; 306(1):73-83. PubMed ID: 12660312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
